Work

Lipoprotein(a) reduction with inclisiran, alirocumab, evolocumab, enlicitide, and lerodalcibep: A systematic review and meta-analysis of randomized controlled trials

Year: 2026

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Journal of clinical lipidology

DOI: 10.1016/j.jacl.2026.03.019

Authors: Martin D. Mulligan, Rahul S. Gandhi, Rishabh Vishwakarma, Romit Bhattacharya

Institutions: Ollscoil na Gaillimhe – University of Galway, Wellington Hospital, North Shore Hospital, Health New Zealand, Trinity College Dublin, Broad Institute, Massachusetts General Hospital

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Harvard University, Harvard Catalyst, Irish Research Council, National Institutes of Health, National Center for Advancing Translational Sciences

Awards: G7189208587, G7357971708, Harvard Clinical and Translational Science Center, CTSA K12 Program at Harvard Medical School

OpenAlex ID: W7147250987

FWCI: 15.37

Cites: 71

Cited by: 8

Related to: 10